Patients Are Left With Few Options as GLP-1 Copycats Disappear

wired.com

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had come to rely on compounded versions is increasingly uncertain.

Visit Site

Patients Are Left With Few Options as GLP-1 Copycats Disappear
WWDC keynote eve photos: a few good indie devsarstechnica.com 2025 Apple iPad review: the 11th-generation iPad is being left behindtheverge.com Open source is the key to new management techniques for diabetes patientszdnet.com Apple fined $162 million for hurting app developers with ‘excessively complex’ privacy optionstheverge.com Google looking for a few good European lobbyistsarstechnica.com You have two months left to update your old LG phonetheverge.com Algebraic Effects for the Rest of Usoverreacted.io I'm Doing a Little Consulting — overreactedoverreacted.io How I Vibed a Proof of Conway’s Conjecture — overreactedoverreacted.io Razer’s new Blade 18 offers Nvidia RTX 50-series GPUs and a dual mode displaytheverge.com Amazon is launching Alexa.com and new app for Alexa Plustheverge.com Alexa Plus is much easier to chat with.theverge.com BusinessWeek: Apple to meet iPhone demand with 3 million units upon launcharstechnica.com Microsoft discovers cryptomining gang hijacking ML-focused Kubernetes clusterszdnet.com These open-source software developers want to give diabetics new tools to manage their conditionzdnet.com The NBA podcast season is just beginning.theverge.com Who knows COBOL?theverge.com Remote work: A nationwide survey challenges WFH perceptionszdnet.com Browser vendor leaks data via open serverzdnet.com Battlefield 6 footage leaks from alpha playtests.theverge.com